Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: Houston TX, Oklahoma City OK
Sponsor: Imunon

Sex: Female

Age: 18+

Code: NCT05739981

Phase 1, Phase 2, Recruiting

Data and Specimen Bank of Patients Diagnosed With, and at High-risk for, Gynecologic Cancers

for
Ovarian Cancer
Location: Charlottesville VA
Sponsor: University of Virginia

Sex: Female

Age: 18+

Code: NCT04170712

Recruiting

Pediatric Ovarian Tissue Banking - Operative Specimens From Females 0-18 Years of Age

for
Benign Cysts Ovarian, Cystectomy, Torsion,
Location: Chicago IL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: Female

Age: 0 - 18

Code: NCT04118712

Recruiting

Tissue Bank of Biological Specimens From Patients With Gynecologic Disease

for
Endometrial Neoplasms, Uterine Cervical Neoplasms,
Location: Washington DC, Durham NC, Pittsburgh PA, Columbus OH
Sponsor: U.S. Army Medical Research and Development Command

Sex: Female

Age: 18+

Code: NCT00299481

Recruiting

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

for
Ovarian Cancer, Endometrial Cancer
Location: Baltimore MD
Sponsor: Sinai Hospital of Baltimore

Sex: Female

Age: 18 - 70+

Code: NCT02188550

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

for
Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer,
Location: Boston MA, Providence RI, Montreal, Fairfax VA, Toronto,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70+

Code: NCT05797168

Phase 1, Phase 2, Recruiting

Repurposing Atovaquone for the Treatment of Platinum-Resistant Ovarian Cancer

for
Ovarian High Grade Serous Adenocarcinoma,
Location: Atlanta GA
Sponsor: Emory University

Sex: Female

Age: 18+

Code: NCT05998135

Phase 2, Recruiting

Modified Immune Cells (TAG72-CAR T Cells) for the Treatment of Patients With Platinum Resistant Epithelial Ovarian Cancer

for
Platinum-Resistant Ovarian Carcinoma
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT05225363

Phase 1, Recruiting

Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer

for
Recurrent Ovarian High Grade Serous Adenocarcinoma,
Location: Philadelphia PA, Charlottesville VA, Winston-Salem NC,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT04633239

Phase 1, Recruiting

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

for
Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II,
Location: Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 18+

Code: NCT06268665

Phase 2, Recruiting

Alternate Day Fasting After Surgery for Patients Undergoing Chemotherapy

for
Ovary Cancer, Endometrial Cancer, Uterine Cancer
Location: Chicago IL
Sponsor: Northwestern University

Sex: Female

Age: 18+

Code: NCT05990426

Recruiting

The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons

for
Endometrial Cancer, Endometrial Cancer Precursors,
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham

Sex: Female

Age: 18 - 70+

Code: NCT03538665

Recruiting

Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies

for
Peritoneal Mesothelioma, Peritoneal Carcinomatosis,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04847063

Phase 1, Recruiting

A Comparison of 2 Standard Doses of Bevacizumab in Combination With Chemotherapy in Epithelial Ovarian Cancer

for
Ovarian Cancer, Platinum-resistant Ovarian Cancer
Location: Abbotsford, Vancouver
Sponsor: British Columbia Cancer Agency

Sex: Female

Age: 18+

Code: NCT04787289

Phase 2, Recruiting

Oral Minoxidil for the Treatment of Recurrent Platinum Resistant Epithelial Ovarian Cancer

for
Ovarian Cancer
Location: Maywood IL
Sponsor: Loyola University

Sex: Female

Age: 18 - 70+

Code: NCT05272462

Phase 2, Recruiting

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

for
Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3+

Code: NCT01441089

Recruiting

Tumor Grade Determines PD-1/PDL-1 Expression

for
Endometrial Cancer, Ovarian Cancer
Location: Jersey City NJ
Sponsor: RWJ Barnabas Health at Jersey City Medical Center

Sex: Female

Age: 0+

Code: NCT04528940

Recruiting

Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline Therapy

for
Ovarian Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: Female

Age: 18+

Code: NCT06083844

Phase 2, Recruiting

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

for
Recurrent Ovarian Cancer, Recurrent Fallopian Tube Cancer,
Location: Boston MA, New York NY, Richmond VA, Columbus OH,
Sponsor: Regeneron Pharmaceuticals

Sex: Female

Age: 18+

Code: NCT03564340

Phase 1, Phase 2, Recruiting

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

for
Low-Grade Serous Ovarian Cancer
Location: Commack NY, Uniondale NY, East White Plains NY,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Female

Age: 18+

Code: NCT06394804

Phase 2, Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial